Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01363453
Other study ID # FE999907
Secondary ID
Status Completed
Phase N/A
First received May 30, 2011
Last updated May 31, 2011
Start date October 2007
Est. completion date July 2008

Study information

Verified date May 2011
Source Ferring Pharmaceuticals
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Observational

Clinical Trial Summary

The aim of the non-interventional study is to document the daily doses in acute and remission therapy, the frequence of doses (1, 2, 3 or 4 times daily), when rectal dosage forms are added and, when and how long steroids are given.


Recruitment information / eligibility

Status Completed
Enrollment 500
Est. completion date July 2008
Est. primary completion date May 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- therapeutic need according to SPC

- written informed consent

Exclusion Criteria:

- contraindications according to SPC

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Investigational , Karlsplatz 18 Aalen
Germany Investigational Site, Goethestraße 5 Ansbach
Germany Investigational Site, Elisenstraße 32 Aschaffenburg
Germany Investigational Site, Haingasse 22 Bad Homburg
Germany Investigational Site, Blankenburger Chaussee 86 Berlin
Germany Investigational Site, Etkar-André-Straße 8 Berlin
Germany Investigational Site, Karl-Marx-Straße 46 Berlin
Germany Investigational Site, Martin-Luther-Straße 134 Berlin
Germany Investigational Site, Mohrenstraße 6 Berlin
Germany Investigational Site, Myslowitzer Straße 49 Berlin
Germany Investigational Site, Plügerstraße 75 Berlin
Germany Investigational Site, Schönhauser Allee 129 Berlin
Germany Investigational Site, Hauptstraße 13 - 15 Birkenfeld
Germany Investigational Site, Kurt-Schumacher-Platz 4 Bochum
Germany Investigational Site, Am Burgweiher 54 Bonn
Germany Investigational Site, Kasernenstraße 22 - 24 Bonn
Germany Investigational Site, Münsterstraße 18 Bonn
Germany Investigational Site, Trauerberg 27/28 Brandenburg
Germany Investigational Site, Hermann-Hesse-Platz 3 Calw
Germany Investigational Site, Moritzstraße 19 Chemnitz
Germany Investigational Site, Osterstraße 44 Cloppenburg
Germany Investigational Site, Leipziger Straße 45 b Cottbus
Germany Investigational Site, Münchner Straße 64 Dachau
Germany Investigational Site, Schäfergraben 5 H Delitzsch
Germany Investigational Site, Hans-Böckler-Straße 20 Dinslaken
Germany Investigational Site, Schadowstraße 42 Düsseldorf
Germany Investigational Site, Simrockstraße 56 Düsseldorf
Germany Investigational Site, Ludwig-Sandberg-Straße 4 Eberswalde
Germany Investigational Site, Neuzeller Landweg 1 Eisenhüttenstadt
Germany Investigational Site, Mühlendamm 23 Elmshorn
Germany Investigational Site, Franz-Busbach-Str. 8 Erftstadt
Germany Investigational Site, Neuwerkstraße 2 Erfurt
Germany Investigational Site, Lehmanns Brink 5 Essen
Germany Investigational Site, Steeler Straße 204 Essen
Germany Investigational Site, Viktoriastraße 5 Euskirchen
Germany Investigational Site, Sorauer Straße 56 Forst
Germany Investigational Site, Im Prüfling 23 Frankfurt Main
Germany Investigational Site, Pfingstweidestraße 4 Frankfurt Main
Germany Investigational Site, Finkenstraße 31 Freising
Germany Investigational Site, Bahnhofstraße 16 Fulda
Germany Investigational Site, Bahnhofplatz 11 Fürth
Germany Investigational Site, Straßburger Weg 4 Gelsenkirchen
Germany Investigational Site, Hinter der Mauer 105 Goch
Germany Investigational Site, Waldweg 1 Göttingen
Germany Investigational Site, Buscheystraße 15 a Hagen
Germany Investigational Site, Drosselstraße 6 A Hamburg
Germany Investigational Site, Eppendorfer Baum 35-37 Hamburg
Germany Investigational Site, Fontenay 1 d Hamburg
Germany Investigational Site, Propst-Paulsen-Straße 2 Hamburg
Germany Investigational Site, Schweriner Straße 1 Hamburg
Germany Investigational Site, Rathausplatz 4 Haßloch
Germany Investigational Site, Kurfürstenanlage 34 Heidelberg
Germany Investigational Site, Luisenstraße 18 a Hettstedt
Germany Investigational Site, Hohensachsener Str. 2 Hirschberg
Germany Investigational Site, Robert-Koch-Straße 2 Hofheim
Germany Investigational Site, M.-Grollmuß-Straße 10 Hoyerswerda
Germany Investigational Site, J.-Lange-Straße 20, Haus 7 Jerichow
Germany Investigational Site, Goethestraße 11 Kiel
Germany Investigational Site, Poggendörper Weg 3-9 Kiel
Germany Investigational Site, Markenbildchenweg 30 Koblenz
Germany Investigational Site, Herzog-Adolph-Straße 13 Konigstein im Taunus
Germany Investigational Site, Schalaunische Strape 6/7 Köthen
Germany Investigational Site, Friesener Straße 41 Kronach
Germany Investigational Site, Auf dem Wall 6 Lindau
Germany Investigational Site, Königstraße 81 Lübeck
Germany Investigational Site, Potsdamer Straße 120A Ludwigsfelde
Germany Investigational Site, Rheingönheimer Str. 121 Ludwigshafen
Germany Investigational Site, Weißdornhag 2 Ludwigshafen
Germany Investigational Site, Pfeifferstraße 10 Magdeburg
Germany Investigational Site, Weißliliengasse 31 Mainz
Germany Investigational Site, Auf dem Sand 76a Mannheim
Germany Investigational Site, Zur Stadthalle 2 Merzig
Germany Investigational Site, Zum Schotzberg 1 a Merzig-Schwemmlingen
Germany Investigational Site, Oldenkirchener Straße 43 Mönchengladbach
Germany Investigational Site, Irisstraße 23 München
Germany Investigational Site, Theodolindenstraße 97 München
Germany Investigational Site, Hammer Straße 95 Münster
Germany Investigational Site, Unterer Markt 26/27 Neumarkt in der Oberpfalz
Germany Investigational Site, Bahnhofstraße 11 Nieder-Olm
Germany Investigational Site, Glogauer Straße 42 Nürnberg
Germany Investigational Site, Kleinreuther Weg 88 Nürnberg
Germany Investigational Site, Weiltinger Straße 11 Nürnberg
Germany Investigational Site, Hauptstraße 19 Oldenburg
Germany Investigational Site, Lutherstraße 22 Oschatz
Germany Investigational Site, Neue Mitte 6 Pohlheim
Germany Investigational Site, Allee nach Sanssouci 7 Potsdam
Germany Investigational Site, Dortustraße 4 Potsdam
Germany Investigational Site, Großbeerenstraße 301 Potsdam
Germany Investigational Site, R.-Breitscheid-Straße 56 Potsdam
Germany Investigational Site, Hohenzollernstraße 7 Recklinghausen
Germany Investigational Site, Bundesstraße 56 Roetgen
Germany Investigational Site, St.-Petersburger Str. 18c Rostock
Germany Investigational Site, Heinz-Meise-Straße 101 Rotenburg
Germany Investigational Site, Tegernseer Str. 100 Rottach-Egern
Germany Investigational Site, Hoerstraße 42 Rottweil
Germany Investigational Site, Neustadter Straße 61 Sonnenberg
Germany Investigational Site, Winterspürer Straße 11 Stockach
Germany Investigational Site, Fichteplatz 1 Strausberg
Germany Investigational Site, Am Wallgraben 99 Stuttgart
Germany Investigational Site, Industriestraße 4 Stuttgart
Germany Investigational Site, Röhre 1 Sundern
Germany Investigational Site, Olgastraße 139 Ulm
Germany Investigational Site, Am Stutenteich 8 Waltrop
Germany Investigational Site, Langenbeckplatz 2 Wiesbaden
Germany Investigational Site, Straße von Triptis 12 Zell

Sponsors (2)

Lead Sponsor Collaborator
Ferring Pharmaceuticals Ferring Arzneimittel GmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prescription habits measured by daily dose of Mesalazine 0 - 8 weeks No
Secondary Compliance measured by questionnaire for drug intake 0 - 8 weeks No
Secondary Quality of Life measured by EuroQol Questionnaire 0 - 8 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT05702879 - Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
Not yet recruiting NCT05953402 - A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Recruiting NCT03950232 - An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT03124121 - Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Phase 4
Not yet recruiting NCT06100289 - A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Phase 3
Withdrawn NCT04209556 - A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis Phase 2
Terminated NCT00061282 - Clotrimazole Enemas for Pouchitis in Children and Adults Phase 1/Phase 2
Recruiting NCT04398550 - SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis N/A
Recruiting NCT04314375 - Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis Phase 4
Active, not recruiting NCT04857112 - Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis Phase 2
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Active, not recruiting NCT04033445 - A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis Phase 2/Phase 3
Recruiting NCT05428345 - A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Active, not recruiting NCT06221995 - Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
Recruiting NCT04767984 - Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Phase 2
Completed NCT02508012 - Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases N/A
Recruiting NCT06071312 - FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach Phase 1/Phase 2
Completed NCT03760003 - Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis Phase 2
Not yet recruiting NCT05539625 - Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis Phase 2